Diurnal Group

DNL:LNLondon Stock Exchange (AIM)

Overview

Company Profile

Diurnal Group plc is a European, UK-headquartered specialty pharmaceutical company dedicated to developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia, Adrenal Insufficiency, Hypogonadism and Hypothyroidism.

Classification

SectorHealthcare
ExchangeLondon Stock Exchange (AIM)
BoardAIM